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ABSTRACT 20 
This work reports the isolation, chemical and functional characterization of two previously 21 
unknown peptides purified from the venom of the scorpion Pandinus imperator, denominated 22 
Pi5 and Pi6. Pi5 is a classical K+-channel blocking peptide containing 33 amino acid residues 23 
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with 4 disulfide bonds. It is the first member of a new subfamily, here defined by the systematic 24 
number α-KTx 24.1.  Pi6 is a peptide of unknown real function, containing only two disulfide 25 
bonds and 28 amino acid residues, but showing sequence similarities to the κ-family of K-26 
channel toxins. The systematic number assigned is κ-KTx2.9.  The function of both peptides was 27 
assayed on Drosophila Shab and Shaker K+-channels, as well as four different subtypes of 28 
voltage-dependent K+-channels: hKv1.1, hKv1.2, hKv1.3 and hKv1.4.  The electrophysiological 29 
assays showed that Pi5 inhibited Shaker B, hKv1.1, hKv1.2 and hKv1.3 channels with Kd=540 30 
nM, Kd= 92 nM and Kd= 77 nM, respectively, other studied channels were not affected. Of the 31 
channels tested only hKv1.2 and hKv1.3 were inhibited at 100 nM concentration of Pi6, the 32 
remaining current fractions were 68% and 77%, respectively. Thus, Pi5 and Pi6 are high 33 
nanomolar affinity non-selective blockers of hKv1.2 and hKv1.3 channels. 34 
 35 
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1. INTRODUCTION 40 
Most scorpion venoms from the family Buthidae, lethal to humans, contain mainly two types of 41 
toxic peptides: the long-chain Na+-channel specific toxins with 60-76 amino acid residues, and 42 
the short-chain peptides with 23-41 amino acid residues, specific for K+-channels (Possani et 43 
al.,1999; Garcia et al., 1998). Toxins from scorpion venom specific for K+-channel have been 44 
widely described (Tytgat et al., 1999; Rodriguez de la Vega and Possani, 2004; Bartok et al, 45 
2015; Kuzmenkov et al, 2016). The venom from the African scorpion Pandinus imperator, from 46 
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the family Scorpionidae, is different because it is not lethal to humans and instead of having 47 
mammalian specific Na+-channel toxins it contains many proteins and peptides with interesting 48 
biological activities, such as imperatoxin activatory (IpTxa) and imperatoxin inhibitory (IpTxi), 49 
both specific for the Ryanodine sensitive Ca2+-channels (Zamudio et et al., 1997a,b), 50 
phospholipin, a heterodimeric phospholipase (Conde et al., 1999) and scorpine, an antibacterial 51 
and antiparasitic peptide (Conde et al., 2000).  Also interesting, more than 10% of its venom is 52 
composed by various peptides that recognize K+-channels (Olamendi-Portugal et al. 1996; 53 
Goméz-Lagunas et al., 1996). The first one described was Pi1, which contains four disulfide 54 
bonds instead of three usually found on K+-channel specific toxins, at the time when it was 55 
described (Olamendi-Portugal et al., 1996). Then Pi2 and Pi3 were found, which differ only by 56 
one amino acid residue in their primary structure, but have a 17 fold difference of activity, 57 
assayed in Shaker B K+ channels (Gomez-Lagunas et al., 1996). Additionally, Pi4 and Pi7 were 58 
described, the first with a Kd of 8.2 nM, whereas the second had no activity against the Shaker 59 
K+-channel (Olamendi-Portugal el al., 1998). The three-dimensional structure (3D) of Pi1 and 60 
Pi4 were determined (Delepierre et al., 1997; Delepierre et al, 1998; Guijarro et al., 2003) 61 
Additionally the 3D structure of Pi7, that lacks a K+ channel blocking potency, was also solved 62 
(Delepierre et al., 1999) in order to reveal possible differences on the folding pattern of the 63 
peptides. The general 3D folding of Pi7 turned out to be identical to the other known K+-channel 64 
specific toxins, however an Arg in position 27 (equivalent to lysine-27 of Charybdotoxin) was 65 
taken as one of the possible differences among these toxins, that would render Pi7 ineffective 66 
against the tested channels. Approximately at the same time, two additional peptides were 67 
identified in this venom, and were called Pi5 and Pi6. The trivial name comes from the 68 
abbreviations of scorpion species (Pandinus imperator) and the number of purified peptides, at 69 
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that time. Systematic nomenclature is now being assigned for both peptides. Pi5 is a new 70 
member of the family α-KTx. The number of amino acids, disulfide bonds and sequence 71 
similarities indicate that it is the first member of the sub-family 24 (systematic number α-KTx 72 
24.1).  Pi6 belongs to the κ-family, with the systematic number assigned κ-KTx 2.9. Their 73 
structures were not published, because the functional activity of the peptides was not clearly 74 
determined. In this communication we fill this gap and describe both peptides; their primary 75 
structure and their inhibitory potential of several ion channel subtype of the of the Shaker family 76 
including Shaker B, Kv1.1-Kv1.4 and on the Shab channel. 77 
 78 
2. Material and Methods 79 
2.1 Source of venom 80 
Living scorpions (approximately 100 animals) of the species Pandinus imperator, from Gabon 81 
(Africa), were bought from a pet-shop (Pet Supplies Plus, Ann Arbor, Michigan, USA) and kept 82 
alive in the laboratory for several years. This occurred before this species became included on 83 
the CITES list for danger of extinction. The scorpions were very well adapted; grow well and 84 
even reproduced in captivity. The venom from adult animals, at that time, was obtained by 85 
electric stimulation under anesthesia with CO2, dissolved in double distilled water and 86 
centrifuged 10,000 g for 15 min. The supernatant was freeze-dried and stored at -20 °C until use. 87 
 88 
2.2 Purification procedure and amino acid sequence determination 89 
The soluble venom was initially fractionated by gel filtration on Sephadex G-50 column. Sub-90 
fractions were further separated by high performance liquid chromatography (HPLC), using a 91 
C18 reverse-phase column (Vydac, Hysperia, CA) of a Waters 600E HPLC system, equipped 92 
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with a variable wavelength detector, and a WIPS 712 automatic sample injector, as described 93 
(Olamendi-Portugal et al., 1996). 94 
The homogeneity of the purified peptides was confirmed by a step-gradient HPLC (only one 95 
symmetric peak), molecular mass determination on LCQDUO Finnigan mass spectrometer (San 96 
Jose, CA), and by direct Edman degradation using an automatic ProSequencer (Millipore model 97 
6400/6600);  Olamendi-Portugal et al., 1996). 98 
The primary structure of both peptides Pi5 and Pi6 was determined using native samples, 99 
samples reduced and alkylated with iodoacetic acid, and after digesting alkylated peptides with 100 
enzymes, such as chymotripsin and Staphyloccocus aureus endopeptidase V8, from which pure 101 
peptides were obtained by HPLC fractionation, essentially as earlier described (Olamendi-102 
Portugal et al., 1996; 2016), and used for completion of the entire amino acid sequence. 103 
The protein sequence data reported in this paper will appear in the UniProt Knowledgebase 104 
under the accession number C0HKB2 for Pi5 and C0HKB3 for Pi6. 105 
 106 
2.3 Functional characterization of pure Pi5 and Pi6 on Drosophila Shab and Shaker B K+-107 
channels 108 
Physiological assays were initially conducted using the expression of Shab and Shaker B K+-109 
channels in Sf9 cells. The insect Sf9 cells were kept in culture at 27 ºC in Grace’s media (Gibco 110 
BRL). The cells were transfected by infecting with a recombinant baculovirus (Autographa 111 
californica nuclear polyhidrosis virus) containing the cDNA of either Shab or Shaker B K+-112 
channels, as previously reported (Klaiber et al., 1990; Islas and Sgiworth, 1999). The cells were 113 
used for the experiments two days after the infection.  114 
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The currents were recorded under whole-cell patch-clamp with an Axopatch 1D (Axon 115 
Instruments INC). Borosilicate glass (KIMAX 51) electrodes were pulled to a 1.5 MOhm 116 
resistance, and used without further treatment. Eigthy percent of the series resistance was 117 
electronically compensated. The currents were filtered in line at 5 KHz, and sampled at 100 118 
µs/point with DIGIDATA 1322A (Axon Instruments, INC). The solutions used were: external 119 
side (in mM): 145 NaCl, 10 CaCl2, 10 HEPES-Na buffer, pH 7.1; internal solution (in mM): 95 120 
KF, 30 KCl, 10 EGTA, 10 HEPES-K buffer, pH 7.1. 121 
 122 
2.4 Functional characterization of pure Pi5 and Pi6 on four voltage-dependent K+-channels 123 
Human peripheral lymphocytes were drawn from healthy volunteers. Mononuclear cells were 124 
isolated using Ficoll-Hypaque density gradient separation technique and were grown in 24-well 125 
culture plates in a 5% CO2 incubator at 37°C in RPMI 1640 medium supplemented with 10% 126 
fetal calf serum (Sigma-Aldrich), 100 µg/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-127 
glutamine (density, 5 x 105 cells per ml) for 2 to 5 days. 5, 7.5 or 10 µg/ml phytohemagglutinin 128 
A (Sigma-Aldrich) was added to the medium to increase K+ channel expression. CHO cells were 129 
grown under standard condition as described previously (Bagdany et al., 2005; Corzo et al., 130 
2008; Grissmer et al., 1994). 131 
Vectors encoding the human Kv1.1, Kv1.2 and Kv1.4 channels were expressed in CHO cells 132 
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s 133 
instructions. hKv1.1 and hKv1.2 genes are coded in pCMV6-GFP plasmid (OriGene 134 
Technologies, Rockville, MD), the vector for hKKv1.4 lacking the N-terminal inactivation 135 
domain was a gift from David Fedida (University of British Coulmbia, Vancuver, Canada). This 136 
latter gene was transiently co-transfected with a plasmid encoding the green fluorescence protein 137 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
(GFP). Currents were recorded 24 h after transfection. GFP positive transfectants were identified 138 
in a Nikon TE2000U fluorescence microscope and used for current recordings (>70% success 139 
rate for co-transfection).  For the measurements of hKv1.3 currents activated lymphocytes were 140 
used (Bartok et al., 2014).  141 
Measurements were carried out using whole-cell patch-clamp recordings using Multiclamp 700B 142 
amplifier and Axon Digidata 1440 digitizer (Molecular Devices, Sunnyvale, CA). Micropipettes 143 
were pulled from GC 150 F-15 borosilicate capillaries (Harvard Apparatus Kent, UK) resulting 144 
in 3- to 5-MΩ resistance in the bath solution. The extracellular solution consisted of 145 mM 145 
NaCl, 5 mM KCl, 1 mM MgCl2, 2.5 mM CaCl2, 5.5 mM glucose, 10 mM HEPES, pH 7.35. Bath 146 
solutions were supplemented with 0.1 mg/ml BSA when toxins were dissolved. The osmolarity 147 
of the extracellular solutions was between 302 and 308 mOsM/L. The pipette filling solution 148 
contained 140 mM KF, 2 mM MgCl2, 1 mM CaCl2, 10 mM HEPES and 11 mM EGTA, pH 7.22.  149 
The osmolarity of the intracellular solutions was 295 mOsM/L.  150 
Whole cell currents were elicited using by voltage steps to +50 mV for variable durations, 151 
ranging between15 ms to 500 ms depending on the channel type, from a holding potential of -152 
100 mV every 15 s. The pClamp10 software package was used to acquire and analyze the data. 153 
Current traces were lowpass-filtered by the analog four-pole Bessel filters of the amplifiers. The 154 
sampling frequency was 2-50 kHz, at least twice the filter cut-off frequency. The effect of the 155 
toxins in a given concentration was determined as remaining current fraction (RF = I/I0, where I0 156 
is the peak current in the absence of the toxin and I is the peak current at equilibrium block at a 157 
given toxin concentration). The Kd was determined from the double reciprocal plot of the 158 
blocked fraction of the current (B=1-RF) where 1/B was plotted against the reciprocal of the 159 
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toxin concentration (1/C). Fitting a straight line to the data points gave Kd as the slope of the line 160 
(1/B=(Kd*1/C)+1). The fit assumed 1:1 stoichiometry for the toxin-channel interaction. 161 
 162 
3. Results and Discussion 163 
3.1 Purification and amino acid sequencing determination 164 
After separation of the whole soluble venom by gel filtration into Sephadex G-50 column, as 165 
described earlier (Olamendi-Portugal et al. 1996), fraction III containing the peptides of interest 166 
was separated by HPLC. Several batches of fraction III (0.5 mg of protein content) was separated 167 
independently, given always the same profile. Figure 1A shows the results obtained. Eight sub-168 
fractions were selected for further purification and characterization. Fractions 1 to 4 of Fig.1A 169 
were characterized as Pi1 to Pi4, and fraction 7 as Pi7 (Olamendi-Portugal et al., 1998; 170 
Delepierre et al., 1999). Components labeled 5 and 6 (marked with asterisks) were used for 171 
sequence determination, and named Pi5 and Pi6. The amino acid sequence of Pi5 is shown in 172 
Fig.1B. Native peptide and the same peptide in its iodoacetic alkylated format permitted the 173 
identification of the first 32 amino acids; the last residue was obtained after sequencing the 174 
peptide labeled “Ch”, which overlaps with residues of the C-terminal region of the peptide, 175 
completing the sequence. This peptide was obtained after digesting 50 µg of the reduced and 176 
alkylated peptide by HPLC (Fig.1A, left side labeled Pi5). The peptide marked with asterisk 177 
gave the sequence from 26-33. The experimental determined molecular weight (average 178 
molecular mass) of the native Pi5 peptide was 3334.00 Da and the theoretically expected was 179 
3334.81 Da, confirming the full sequence, within the experimental error of the mass 180 
spectrometer used for this analysis. The peptide contains 8 cysteines that are forming 4 disulfide 181 
bonds. Using the same procedure the amino acid sequence of peptide Pi6 was determined as 182 
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shown in Fig.1C. The first 24 amino acid residues were identified by direct Edman degradation 183 
of native and native-alkylated samples. Alkylation of cysteines was essential for the correct 184 
identification of the thiol containing amino acids. The complete sequence was obtained after 185 
digesting 50 µg of peptide Pi6 with endopeptidase V8, whose separation profile on HPLC is 186 
shown on the right inset panel of Fig.1A, labeled Pi6 and marked with asterisk. This peptide 187 
gave the sequence from amino acid Ala21 to Pro28. The molecular weight experimentally 188 
determined (average molecular mass) for this peptide was 3126.5 Da and the theoretical 189 
molecular weight was 3127.2, within the experimental error of the spectrometer used for this 190 
analysis. This peptide has 4 cysteines forming only two disulfide bonds. 191 
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 192 
Figure 1: Purification and amino acid sequence of Pi5 and Pi6 193 
A. Fraction III from Sephadex G-50 column (0.5 mg) was separated by HPLC using an 194 
analytical C18 reverse-phase column (4.6 x 250 mm), with a linear gradient from solution A 195 
(0.12% trifluoacetic acid –TFA- in water) to 40% solution B (0.10% TFA in acetonitrile). Sub-196 
fraction 5 (labeled with asterisk) was homogeneous Pi5, which was digested with chymotripsin 197 
and separated again in the same conditions, as indicated in the inset figure labeled Pi5. The 198 
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asterisk indicates the peptide whose sequence allowed completion of the amino acid sequence 199 
shown in letter B, from position 26 to 33 (underlabeled with .Ch.). Similarly, the sub-fraction 6 200 
(labeled with asterisk) was the homogeneous peptide Pi6, which was digested with Protease V8 201 
from Staphylococcus aureus, and separated in the same conditions, as indicated in the insert 202 
labeled Pi6. The labeled peptide with asterisk was sequenced and permitted completion of the 203 
sequence from amino acids in position 21 to 28 (underlined .V8.). Letters B and C show the full 204 
amino acid sequence for both peptides, where “Direct” means amino acid sequence obtained 205 
with a reduced and alkylated sample of each peptide. 206 
 207 
3.2 Effects of Pi5 and Pi6 on Shab and Shaker K+-channels  208 
Fig. 2A demonstrates that Pi5 is a toxin that reversibly blocks, Drosophila Shaker B K+ channels 209 
with low affinity. The left panel presents a family of control K+ currents (see Figure legend), 210 
note that upon addition of 1.5 µM Pi5, to the extracellular solution, the size of IK was drastically 211 
reduced (~80%, middle panel). Inhibition was fully reversed by washing the cell with the control 212 
solution (right panel). Experiments repeated at lower Pi5 concentrations show that Pi5 simply 213 
scales down the currents without changing its kinetics. The I-V relationship of the traces shown 214 
in Fig. 2B demonstrates that, as commonly found with Kv channel blocker toxins, the fraction of 215 
the channels blocked by Pi5 is independent of the applied voltage. The fit to the dose-response 216 
relationship resulted in a Kd of 540 nM (Fig. 2C) with Hill coefficient close to 1 indicating that 217 
the Pi5 blocks Shaker channels with a 1:1 stoichiometry. The double reciprocal plot (Fig. 2 C 218 
inset) could be well-fit using linear regression (r=0.995), the Kd values obtained by the two 219 
methods were comparable. In contrast to the above observations, addition of 1.5 µM Pi5 to the 220 
extracellular solution did not inhibit significantly Drosophila Shab K+ channels (Figures 2D and 221 
2E). Pi6 on the other hand did not inhibit the either Shaker B or Shab (See Supplementary Figure 222 
1). 223 
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 224 
Figure 2:  Effect of Pi5 on Drosophila K+ channels 225 
 (A) K+ currents through dShaker B channels. K+-currents were elicited every 15-sec by 30-ms 226 
pulses from -20 to +60 mV applied in 10 mV increments from a holding potential of -80 mV, 227 
before (left panel, labeled Control), during (middle panel, labeled Pi5) and after (labeled 228 
Recovery) the addition of 1.5 µM Pi5 to the external solution. (B) Current-Voltage relationship 229 
of the traces in A: closed circles: control IK, open symbols: IK with 1.5 µM Pi5 in the external 230 
solution, closed triangles: IK after washing the cell with the control solution.  The inset shows 231 
that the block (1.5 µM Pi5) is not voltage dependent. (C) Fractional block vs. [Pi5], the fractional 232 
block (F.b) was calculated as F.b=1-(I/I0), where I0 and I are the peak current in the control and 233 
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in the presence of Pi5, respectively. The line is the least squares fit of the points with the 234 
Michaelis-Menten equation, with Kd= 540 nM. The inset shows the expected linear double-235 
reciprocal plot of the points (r=0.995). (D) K+ currents through dShab channels. The figure 236 
shows two superimposed currents evoked by a 30mV/30ms pulse applied from -80 mV, before 237 
and during addition of 1.5 µM Pi5, as indicated. (E) Current-voltage relationship before and in 238 
the presence of 1.5 µM Pi5 from traces as in D. There was no blockage. 239 
 240 
3.3 Effects of Pi5 and Pi6 on hKv1.1, hKv1.2, hKv1.3 and hKv1.4 channels. 241 
Based on the similarity of Pi5 and Pi6 with other known α-KTx toxins (see also below) and the 242 
literature available for the selectivity of similar peptides ((Camargos et al., 2011; Gomez 243 
Lagunas et al., 1997; Mouhat et al., 2004; Peter et al., 2000)), the following Shaker-related 244 
human ion channels were selected for the study: Kv1.1, Kv1.2, Kv1.3 and Kv1.4. These channels 245 
were either expressed heterologously in CHO cells (Kv1.1, Kv1.2 and Kv1.4) or were recorded 246 
in human peripheral blood lymphocytes where the dominant voltage-gated K+ channel is Kv1.3. 247 
Our recording condition (no Ca2+ in the pipette to evoke Ca2+-activated K+ channels) and the 248 
stimulation of the K+ channel expression (activation of the cells by PHA, see methods) ensured 249 
that the voltage-gated current recorded in these cells is a K+ current through Kv1.3 (Peter et al., 250 
2001).  The toxins were applied using a custom built microperfusion system with a very small 251 
perfusion rate (200 µL/min). At this perfusion rate the speed and the completeness of the 252 
solution exchange had to be tested repeatedly. The positive controls for perfusion were either 253 
quick and fully reversible blockers of the channels (e.g. TEA for Kv1.3 and Kv1.1 and ChTx for 254 
Kv1.2 (Bartok et al., 2014)) or the recording chamber was perfused with a modified bath solution 255 
containing 150 mM K+ and reduction of the peak currents was used as an indicator of the 256 
solution exchange.   257 
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The effect of Pi5 on the whole cell current carried by hKv1.2 channels is shown in Fig. 3A.  The 258 
figure shows that Pi5 in 100 nM concentration inhibits ~80% of the whole-cell current upon 259 
reaching block equilibrium (perfusion of the recording chamber with ChTx was used as a 260 
positive control of the solution exchange).  The comparison of the currents recorded in the 261 
presence and absence of the blocker indicates that the kinetics of the whole-cell currents are 262 
unaffected by the application of Pi5. The block of the hKv1.2 channels was fully but slowly 263 
reversible by perfusing the recording solution with toxin-free extracellular solution (Fig. 3B, 264 
indicated by the arrow labeled wash). The interepisode time during the recording was 15s and the 265 
wash-out is complete in ~50 episodes which correspond to ~12-13 min. The kinetics of the 266 
recovery from block followed a single exponential time-course (fit not shown) with a time 267 
constant of 245+/- 26 s (n=3). The limited amount of the purified peptides allowed the dose-268 
response relationship to be determined over a limited range of Pi5 concentrations, between 5 and 269 
100 nM (Fig. 3C). The best fit linear regression to the double reciprocal plot shown in Fig. 3C 270 
resulted in a Kd of 92 nM (R2=0.99).  Pi5 inhibited the hKv1.3 current expressed in human T 271 
cells with similar potency, the remaining current fractions of hKv1.2 and hKv1.3 currents were 272 
0.29+/-0.03 (n=4) and 0.39+/-0.02 (n=5), respectively, in the presence of 100 nM Pi5.  Fig. 3D 273 
shows the raw current traces in the presence and absence of 100 nM Pi5, 10 mM TEA was used 274 
as a positive control for solution exchange. The kinetics of the blocked hKv1.3 current did not  275 
 276 
 277 
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 278 
 279 
Figure 3:  Block of Kv1.2 and Kv1.3 channels by Pi5  280 
A) Whole-cell potassium currents through hKv1.2 channels were evoked from a transiently 281 
transfected CHO cells in response to depolarizing pulses to +50 mV from a holding potential of -282 
100 mV every 15s.  The current traces were recorded in the absence of the toxins (control, 283 
indicated by arrow), after equilibration of the block in the presence of Pi5 (indicated by arrow) in 284 
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100 nM concentration.  Charybdotoxin (ChTx, arrow, 14 nM) was used as a positive control. B) 285 
Development of and recovery from block of Kv1.2 by Pi5. Peak currents were determined during 286 
repeated depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM 287 
Pi5  or with the toxin-free bath solution (labeled “wash”). C) Double-reciprocal plot of the dose-288 
response of Pi5 on hkV1.2. See methods for details. The linear regression (1/B=(Kd*1/C)+1) 289 
resulted in a Kd of 92 nM (R2=0.99). D) Whole-cell potassium currents through hKv1.3 channels 290 
were evoked from in activated human peripheral lymphocytes in response to depolarizing pulses 291 
to +50 mV from a holding potential of -100 mV every 15s.  The current traces were recorded in 292 
the absence of the toxins (control, indicated by arrow), after equilibration of the block in the 293 
presence of Pi5  in 100 nM concentration (arrow). Tetraethylammonium (TEA, arrow, 10 mM) 294 
was used as a positive control. D) Development of and recovery from block of Kv1.3 by Pi5. 295 
Peak currents were determined during repeated depolarizations to +50 mV, arrows indicate the 296 
start of the bath perfusion with 10 nM Pi5 or 100 nM Pi5 or the toxin-free bath solution (arrow 297 
labeled wash).  E) Double-reciprocal plot of the dose-response of Pi5 on hKv1.3. See methods 298 
for details. The linear regression (1/B=(Kd*1/C)+1) resulted in a Kd of 77 nM (R2=0.99). 299 
 300 
differ from the control one, similar to the results obtained for the inhibition of the hKv1.2 301 
currents. The block of the Kv1.3 current by Pi5 was fully reversible, as indicated by the full 302 
recovery of the peak currents following the application of Pi5 in 10 nM and 100 nM 303 
concentrations (Fig. 3 E, indicated by arrows). The wash-out of the peptide was complete in ~15 304 
episodes corresponding to ~225 s. The kinetics of the recovery from block followed a single 305 
exponential time-course (fit not shown) with a time constant of 80+/-6 s (n=4). The best fit linear 306 
regression to the double reciprocal plot shown in Fig. 3F resulted in a Kd of 77 nM (R2=0.99).  307 
The same set of experiments was repeated using Pi6 and the effect of this peptide at 100 nM 308 
concentration was studied on the hKv1.2 and hKv1.3 currents. Panels A and C of Fig. 4 show the 309 
raw current traces whereas panels B and D show the change in the peak currents upon 310 
application and wash-out of Pi6 when cells expressing hKv1.2 (A, B) or hKv1.3 (C,D) channels  311 
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 313 
Figure 4:  Block of Kv1.2 and Kv1.3 channels by Pi6 314 
A) Whole-cell potassium currents through hKv1.2 channels were evoked from a transiently 315 
transfected CHO cells in response to depolarizing pulses to +50 mV from a holding potential of -316 
100 mV every 15s.  The current traces were recorded in the absence of the toxins (control, 317 
indicated by arrow), after equilibration of the block in the presence of Pi6 (indicated by arrow) in 318 
100 nM concentration.  Charybdotoxin (ChTx, arrow, 14 nM) was used as a positive control. B) 319 
Development of and recovery from block of Kv1.2 by Pi6. Peak currents were determined during 320 
repeated depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM 321 
Pi6 or with the toxin-free bath solution (labeled “wash”). C) Whole-cell potassium currents 322 
through hKv1.3 channels were evoked from in activated human peripheral lymphocytes in 323 
response to depolarizing pulses to +50 mV from a holding potential of -100 mV every 15s.  The 324 
current traces were recorded in the absence of the toxins (control, indicated by arrow), after 325 
equilibration of the block in the presence of Pi6 in 100 nM concentration (arrow). 326 
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Tetraethylammonium (TEA, arrow, 10 mM) was used as a positive control. D) Development of 327 
and recovery from block of Kv1.3 by Pi6. Peak currents were determined during repeated 328 
depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM Pi6 or the 329 
toxin-free bath solution (arrow labeled wash). 330 
 331 
in whole-cell patch-clamp.  The raw traces recorded at +50 mV test potential show that Pi6 is a 332 
low affinity blocker of both hKv1.2 and hKv1.3. The statistical analysis of the remaining current 333 
fractions upon reaching block equilibrium resulted in RF= 0.68+/-0.02 (n=5) and RF=0.77+/-334 
0.01 (n=4) for hKv1.2 and hKv1.3 currents, respectively. The recovery from the block of both 335 
hKv1.2 (B) and hKv1.3 (D) was complete in ~300 s.  The amount of the purified peptides was 336 
not sufficient to obtain the dose-response relationship of inhibitions for either hKv1.3 or hKv1.3.   337 
Supplementary Figure 2 shows on the other hand, that neither Pi5 nor Pi6 inhibits hKv1.1 or 338 
hKv1.4 channels in 100 nM concentration. To obtain a more precise determination of the peak 339 
currents in hKv1.4 expressing cells we transfected the N-terminal inactivation particle deleted 340 
hKv1.4 construct (Kv1.4-∆N). Supplementary Figure 2A and Supplementary Figure 2C show 341 
hKv1.1 and hKv1.4 currents, respectively, recorded before application of the peptides and after 342 
the 10th pulse in the toxin-containing solution. The overlapping current traces indicate the lack of 343 
block, similarly to the constant peak currents regardless of the presence or absence of the 344 
peptides shown in Supplementary Figure 2B and Supplementary Figure 2D. 345 
The effect of Pi5 and Pi6 in 100 nM concentration on the ion channels included in this study is 346 
summarized in Fig. 5. The data show that these peptides inhibit significantly, the human Kv1.2 347 
and Kv1.3 channels and that Pi5 is slightly more potent blocker of these channels than Pi6. 348 
Furthermore, Pi5 also inhibits Shaker B channels with low affinity.  349 
 350 
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 351 
Figure 5: Selectivity profile of Pi5 and Pi6  352 
A) Bars indicate the remaining current fractions at equilibrium block of the indicated channels by 353 
100 nM Pi5 (empty bars) or 100 nM Pi6 (hatched bars). For the expression systems, solutions 354 
and voltage protocols see Materials and Methods and Figs 2-4 and supplementary Fig. 2. Error 355 
bars indicate SEM (n=3-6). 356 
 357 
3.4 Comparative analysis of amino acid sequence of the Pi toxins 358 
Fig.6 shows the amino acid sequence of K+-channel blocking peptides isolated from Pandinus 359 
imperator venom. The similarities of these sequences are relatively low (39 to 55% identity 360 
taking Pi1 as the reference), and it is practically nonexistent for Pi6 (14%). The peptides Pi1, Pi4, 361 
Pi5 and Pi7 have four disulfide bonds; Pi2 and Pi3 have 3 and Pi6 only 2. The longest ones are 362 
Pi4 and Pi7, containing 37 amino acid residues, whereas Pi6 has only 28. The conserved residues 363 
are shaded shown, mainly cysteines. Pi2 and Pi3 differ only by one amino acid in position 7, 364 
which is a Proline for Pi2 and Glutamic acid for Pi3. 365 
The general pattern of ion channel inhibition by Pi5 matches to those of the Pandinus imperator 366 
toxins, these peptides inhibit Kv1.2 and Kv1.3 channels with nM-pM affinities without  367 
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 368 
significant selectivity for either of the channels (Fig. 6). Pi6, on the other hands, is different from 369 
the other members since it does not inhibit Shaker, and has very low affinity to Kv1.2 and Kv1.3. 370 
These properties of Pi6 match to the systemic nomenclature (see below).  371 
 372 
Figure 6: Comparative sequences of Pandinus imperator toxins 373 
Amino acid sequences of the K+-channel peptides isolated from Pandinus imperator and 374 
percentage of identity (Iden.) compared to Pi1. Cons.1 and Cons.2 stand for consensus on the 375 
relative positions of the cysteine residues in Pi1-Pi4, Pi7 and Pi5, Pi6, respectively. Amino acids 376 
in identical positions are highlighted in gray. References (ref) in this figure correspond to:  (1) 377 
(Mouhat et al., 2004), (2) (Peter et al., 2000), (3) (Gomez Lagunas et al., 1997), (4) (Rogowski et 378 
al., 1996), (5) (Peter et al., 2001), (6) (Gomez-Lagunas et al., 1996), (7) (M'Barek et al., 2003) 379 
and (8) (Olamendi-Portugal et al., 1998). 380 
 381 
The databank KALIUM (see reference Kuzmenkov et al..2016), by November 2016 listed 174 382 
distinct amino acid sequence belonging to α, β, δ, κ and λ families, from which Pi5 and Pi6 383 
belong to α and κ families, respectively. When this manuscript was been prepared another new 384 
sub-family (α-KTx 31.1) was described (ElFessi-Magouri et al., 2016). Pi5 is the first example of 385 
a new subfamily, and the systematic number assigned was α-KTx 24.1 (See Supplementary 386 
Fig.3). We found that the subfamily number 25 was never used. New coming sequences, that 387 
according to the initial proposed nomenclature (Tytgat et al, 1999) justifies the assignation of 388 
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new member for systematic classification, should use the number 25.  The physiological effects 389 
of Pi5 described here, certainly justifies including this sequence as a bona fide α-KTx peptide.  390 
This classification was supported in addition by the phylogenetic analysis conducted, using the 391 
number one sequence of each subfamily described until now.  392 
 393 
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Figure 7: Unrooted phylogenetic tree of α-KTx  394 
A multiple sequence alignment of 30 sequences were retrieved from public databases, literature 395 
or unpublished results from our laboratory. The evolutionary history was inferred using the 396 
Neighbor-Joining method. The tree is drawn to scale, with branch lengths in the same units as 397 
those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary 398 
distances were computed using the Poisson correction method and are in the units of the number 399 
of amino acid substitutions per site. Evolutionary analyses were conducted in MEGA7. 400 
 401 
κ-KTx2.1 OmTx1     –DPCYEVCLQQHGNVKECEEACKHPVE 402 
κ-KTx2.2 OmTx2     -DPCYEVCLQQHGNVKECEEACKHPVEY 403 
κ-KTx2.3 OmTx3     NDPCEEVCLQHTGNVKACEEACQ----- 404 
κ-KTx2.4 OmTx4     -DPCYEVCLQQHGNVKECEEACKHP--- 405 
κ-KTx2.5 OcyC8     YDACVNACLEHHPNVRECEEACKNPVPP 406 
κ-KTx2.6 OcyC9     FPPCVEVCVQHTGNVKECEAACGE---- 407 
κ-KTx2.7 HSP053C.1 -NACIEVCLQHTGNPAECDKACDK---- 408 
κ-KTx2.8 HSP053C.2 GNACIEVCLQHTGNPAECDKPCDK---- 409 
κ-KTx2.9 Pi6       VDACYEACMHHHMNSDDCIEACKNPVPP 410 
 411 
Figure 8: Amino acid sequence of the family κ-KTx 2 412 
Pi6 is the number 9 of this subfamily. 413 
 414 
Relatively limited information is available for the inhibition of K+ channels by κ-KTx peptides 415 
albeit the family consists of 9 members now. The only peptide studied in this group so far is κ-416 
KTx 2.5 (OcyC8) where a low affinity inhibition of Kv1.1 (Kd=217 µM) and Kv1.4 (Kd=71 417 
µM) were reported earlier (Camargos et al., 2011). These peptides do not conform to the general 418 
pattern of the peptides inhibiting K+ channels with high affinity, Pi6 has less cysteines to make 419 
disulfide bridges and the 2 antiparallel beta sheets plus the α helix cannot be assigned to Pi6. 420 
Regardless, it is very interesting that Pi6 does inhibit (albeit with low affinity) voltage gated K+ 421 
channels (this communication) which might be related to an unspecific effect of charged amino 422 
acid residues. Thus, the real effect of this peptide remains to be clarified, if any. 423 
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In summary, we have identified and biochemically characterized two novel peptides from 424 
Pandinus imperator, and assigned the systemic names of α-KTx 24.1 (Pi5) and κ-KTx 2.9 (Pi6) 425 
to them.  Due to the relatively low affinity of Kv1.2 or kv1.3 inhibition the applicability of these 426 
peptides as research or therapeutic purposes is unlikely. On the other hand, our results contribute 427 
to the description of the biodiversity of the scorpion peptides regarding their primary structure 428 
and biological function. 429 
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FIGURE  LEGENDS 544 
 545 
Figure 1: Purification and amino acid sequence of Pi5 and Pi6 546 
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A. Fraction III from Sephadex G-50 column (0.5 mg) was separated by HPLC using an 547 
analytical C18 reverse-phase column (4.6 x 250 mm), with a linear gradient from solution A 548 
(0.12% trifluoacetic acid –TFA- in water) to 40% solution B (0.10% TFA in acetonitrile). Sub-549 
fraction 5 (labeled with asterisk) was homogeneous Pi5, which was digested with chymotripsin 550 
and separated again in the same conditions, as indicated in the inset figure labeled Pi5. The 551 
asterisk indicates the peptide whose sequence allowed completion of the amino acid sequence 552 
shown in letter B, from position 26 to 33 (under labeled with .Ch.). Similarly, the sub-fraction 6 553 
(labeled with asterisk) was the homogeneous peptide Pi6, which was digested with Protease V8 554 
from Staphylococcus aureus, and separated in the same conditions, as indicated in the insert 555 
labeled Pi6. The labeled peptide with asterisk was sequenced and permitted completion of the 556 
sequence from amino acids in position 21 to 28 (underlined .V8.). Letters B and C show the full 557 
amino acid sequence for both peptides, where “Direct” means amino acid sequence obtained 558 
with a reduced and alkylated sample of each peptide. 559 
 560 
Figure 2:  Effect of Pi5 on Drosophila K+ channels 561 
 (A) K+ currents through dShaker B channels. K+-currents were elicited every 15-sec by 30-ms 562 
pulses from -20 to +60 mV applied in 10 mV increments from a holding potential of -80 mV, 563 
before (left panel, labeled Control), during (middle panel, labeled Pi5) and after (labeled 564 
Recovery) the addition of 1.5 µM Pi5 to the external solution. (B) Current-Voltage relationship 565 
of the traces in A: closed circles: control IK, open symbols: IK with 1.5 µM Pi5 in the external 566 
solution, closed triangles: IK after washing the cell with the control solution.  The inset shows 567 
that the block (1.5 µM Pi5) is not voltage dependent. (C) Fractional block vs. [Pi5], the fractional 568 
block (F.b) was calculated as F.b=1-(I/I0), where I0 and I are the peak current in the control and 569 
in the presence of Pi5, respectively. The line is the least squares fit of the points with the 570 
Michaelis-Menten equation, with Kd= 540 nM. The inset shows the expected linear double-571 
reciprocal plot of the points (r=0.995). (D) K+ currents through dShab channels. The figure 572 
shows two superimposed currents evoked by a 30mV/30ms pulse applied from -80 mV, before 573 
and during addition of 1.5 µM Pi5, as indicated. (E) Current-voltage relationship before and in 574 
the presence of 1.5 µM Pi5 from traces as in D. There was no blockage. 575 
 576 
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Figure 3:  Block of Kv1.2 and Kv1.3 channels by Pi5  577 
A) Whole-cell potassium currents through hKv1.2 channels were evoked from a transiently 578 
transfected CHO cells in response to depolarizing pulses to +50 mV from a holding potential of -579 
100 mV every 15s.  The current traces were recorded in the absence of the toxins (control, 580 
indicated by arrow), after equilibration of the block in the presence of Pi5 (indicated by arrow) in 581 
100 nM concentration.  Charybdotoxin (ChTx, arrow, 14 nM) was used as a positive control. B) 582 
Development of and recovery from block of Kv1.2 by Pi5. Peak currents were determined during 583 
repeated depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM 584 
Pi5  or with the toxin-free bath solution (labeled “wash”). C) Double-reciprocal plot of the dose-585 
response of Pi5 on hkV1.2. See methods for details. The linear regression (1/B=(Kd*1/C)+1) 586 
resulted in a Kd of 92 nM (R2=0.99). D) Whole-cell potassium currents through hKv1.3 channels 587 
were evoked from in activated human peripheral lymphocytes in response to depolarizing pulses 588 
to +50 mV from a holding potential of -100 mV every 15s.  The current traces were recorded in 589 
the absence of the toxins (control, indicated by arrow), after equilibration of the block in the 590 
presence of Pi5 in 100 nM concentration (arrow). Tetraethylammonium (TEA, arrow, 10 mM) 591 
was used as a positive control. D) Development of and recovery from block of Kv1.3 by Pi5. 592 
Peak currents were determined during repeated depolarizations to +50 mV, arrows indicate the 593 
start of the bath perfusion with 10 nM Pi5 or 100 nM Pi5 or the toxin-free bath solution (arrow 594 
labeled wash).  E) Double-reciprocal plot of the dose-response of Pi5 on hkV1.3. See methods 595 
for details. The linear regression (1/B=(Kd*1/C)+1) resulted in a Kd of 77 nM (R2=0.99). 596 
 597 
Figure 4:  Block of Kv1.2 and Kv1.3 channels by Pi6 598 
A) Whole-cell potassium currents through hKv1.2 channels were evoked from a transiently 599 
transfected CHO cells in response to depolarizing pulses to +50 mV from a holding potential of -600 
100 mV every 15s.  The current traces were recorded in the absence of the toxins (control, 601 
indicated by arrow), after equilibration of the block in the presence of Pi6 (indicated by arrow) in 602 
100 nM concentration.  Charybdotoxin (ChTx, arrow, 14 nM) was used as a positive control. B) 603 
Development of and recovery from block of Kv1.2 by Pi6. Peak currents were determined during 604 
repeated depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM 605 
Pi6 or with the toxin-free bath solution (labeled “wash”). C) Whole-cell potassium currents 606 
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through hKv1.3 channels were evoked from in activated human peripheral lymphocytes in 607 
response to depolarizing pulses to +50 mV from a holding potential of -100 mV every 15s.  The 608 
current traces were recorded in the absence of the toxins (control, indicated by arrow), after 609 
equilibration of the block in the presence of Pi6 in 100 nM concentration (arrow). 610 
Tetraethylammonium (TEA, arrow, 10 mM) was used as a positive control. D) Development of 611 
and recovery from block of Kv1.3 by Pi6. Peak currents were determined during repeated 612 
depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM Pi6 or the 613 
toxin-free bath solution (arrow labeled wash).  614 
 615 
Figure 5: Selectivity profile of Pi5 and Pi6  616 
A) Bars indicate the remaining current fractions at equilibrium block of the indicated channels by 617 
100 nM Pi5 (empty bars) or 100 nM Pi6 (hatched bars). For the expression systems, solutions 618 
and voltage protocols see Materials and Methods and Figs 2-4 and supplementary Fig. 2. Error 619 
bars indicate SEM (n=3-6). 620 
 621 
Figure 6: Comparative sequences of Pandinus imperator toxins 622 
Amino acid sequences of the K+-channel peptides isolated from Pandinus imperator and 623 
percentage of identity (Iden.) compared to Pi1. Cons.1 and Cons.2 stand for consensus on the 624 
relative positions of the cysteine residues in Pi1-Pi4, Pi7 and Pi5, Pi6, respectively. Amino acids 625 
in identical positions are highlighted in gray. References (ref) in this figure correspond to:  (1) 626 
(Mouhat et al., 2004), (2) (Peter et al., 2000), (3) (Gomez Lagunas et al., 1997), (4) (Rogowski et 627 
al., 1996), (5) (Peter et al., 2001), (6) (Gomez-Lagunas et al., 1996), (7) (M'Barek et al., 2003) 628 
and (8) (Olamendi-Portugal et al., 1998). 629 
 630 
Figure 7: Unrooted phylogenetic tree of α-KTx  631 
A multiple sequence alignment of 30 sequences were retrieved from public databases, literature 632 
or unpublished results from our laboratory. The evolutionary history was inferred using the 633 
Neighbor-Joining method. The tree is drawn to scale, with branch lengths in the same units as 634 
those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary 635 
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distances were computed using the Poisson correction method and are in the units of the number 636 
of amino acid substitutions per site. Evolutionary analyses were conducted in MEGA7. 637 
 638 
Figure 8: Amino acid sequence of the family κ-KTx 2 639 
Pi6 is the number 9 of this subfamily. 640 
 641 
Legend for Supplementary Figures 642 
 643 
Supplementary Figure 1: Pi6 effect on Shaker channels  644 
Pi6 does not inhibit Shaker channels. Shaker IK evoked by delivering 30-ms activation pulses 645 
from -40 to +50 mV, in 10 mV increments, before (left panel), and after addition of 100 nM Pi6 646 
to the extracellular solution (right panel). IK was not significantly inhibited by Pi6. HP= -80 mV. 647 
Time between pulses was 20-sec to allow full recovery from inactivation.  648 
 649 
Supplementary Figure 2: Lack of inhibition of hKv1.1 and hKv1.4 by Pi5 and Pi6   650 
A, C) Whole-cell potassium currents through hKv1.1 (A) or hKv1.4 channels (C) were evoked 651 
from a transiently transfected CHO cells in response to depolarizing pulses to +50 mV from a 652 
holding potential of -100 mV every 15s.  The current traces were recorded in the absence of the 653 
toxins (control, indicated by arrow), after at least 10 episodes in of Pi5 or Pi6 (indicated by 654 
arrows) in 100 nM concentration.  Tetraethylammonium (TEA, arrow, 0.3 mM) was used as a 655 
positive control in A.  Positive control for hKv1.4  was obtained by perfusing the recording 656 
chamber with a bath solution congaing 150 mM K+ (not shown). B,D) Peak hKv1.1 (B) and 657 
hKv1.4 currents (D) in 100 nM Pi5 or Pi6. Peak currents were determined during repeated 658 
depolarizations to +50 mV, arrows indicate the start of the bath perfusion with 100 nM Pi5 or 659 
100 nM Pi6. 660 
 661 
Supplementary Figure 3: Amino acid sequence of α-KTx toxins 662 
Only the number 1 toxin of each subfamily was selected. The number α-KTx 25 is empty. 663 
 664 
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 665 
 666 
 667 
 668 
 669 
 670 
 671 
 672 
 673 
Supplementary Figure 1:  Pi6 effect on Shaker channels  674 
Pi6 does not inhibit Shaker channels. Shaker IK evoked by delivering 30-ms activation pulses 675 
from -40 to +50 mV, in 10 mV increments, before (left panel), and after addition of 100 nM Pi6 676 
to the extracellular solution (right panel). IK was not significantly inhibited by Pi6. HP= -80 mV. 677 
Time between pulses was 20-sec to allow full recovery from inactivation.  678 
 679 
 680 
 681 
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 682 
 683 
Supplementary Figure 2:  Pi6 does not inhibit Shaker channels. Shaker IK evoked by  684 
delivering 30-ms activation pulses from -40 to +50 mV, in 10 mV increments, before (left panel), 685 
and after addition of 100 nM Pi6 to the extracellular solution (right panel). IK was not 686 
significantly inhibited by Pi6. HP= -80 mV. Time between pulses was 20-sec to allow full 687 
recovery from inactivation.  688 
 689 
 690 
Supplementary Figure 3: Amino acid sequence of α-KTx toxins 691 
•-KTx-1.1   QFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS 692 
•-KTx-2.1   TIINVKCTSPKQCSKPCKELYGSSAGAKCMNGKCKCYNN 693 
•-KTx-3.1   GVEINVKCSGSPQCLKPCKDAGMRFGKCMNRKCHCTPK 694 
•-KTx-4.1   VFINAKCRGSPECLPKCKEAIGKAAGKCMNGKCKCYP 695 
•-KTx-5.1   AFCNLRMCQLSCRSLGLLGKCIGDKCECVKH 696 
•-KTx-6.1   LVKCRGTSDCGRPCQQQTGCPNSKCINRMCKCYGC 697 
•-KTx-7.1   TISCTNPKQCYPHCKKETGYPNAKCMNRKCKCFGR 698 
•-KTx-8.1   VSCEDCPEHCSTQKAQAKCDNDKCVCEPI 699 
•-KTx-9.1   VGCEECPMHCKGKNAKPTCDDGVCNCNV 700 
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•-KTx-10.1  AVCVYRTCDKDCKRRGYRSGKCINNACKCYPY 701 
•-KTx-11.1  DEEPKESCSDEMCVIYCKGEEYSTGVCDGPQKCKCSD 702 
•-KTx-12.1  WCSTCLDLACGASRECYDPCFKAFGRAHGKCMNNKCRCYT 703 
•-KTx-13.1  ACGSCRKKCKGSGKCINGRCKCY 704 
•-KTx-14.1  TPFAIKCATDADCSRKCPGNPSCRNGFCACT 705 
•-KTx-15.1  QNETNKKCQGGSCASVCRRVIGVAAGKCINGRCVCYP 706 
•-KTx-16.1  DLIDVKCISSQECWIACKKVTGRFEGKCQNRQCRCY 707 
•-KTx-17.1  QTQCQSVRDCQQYCLTPDRCSYGTCYCKTT 708 
•-KTx-18.1  TGPQTTCQAAMCEAGCKGLGKSMESCQGDTCKCKA 709 
•-KTx-19.1  AACYSSDCRVKCVAMGFSSGKCINSKCKCYK 710 
•-KTx-20.1  GCTPEYCSMWCKVKVSQNYCVKNCKCPGR 711 
•-KTx-21.1  GKFGKCKPNICAKTCQTEKGKGMGYCNKTECVCSEW  712 
•-KTx-22.1  EVDGRTATFCTQSICEESCKRQNKNGRCVIEAEGSLIYHLCKCY 713 
•-KTx-23.1  AAAISCVGSPECPPKCRAQGCKNGKCMNRKCKCYYC 714 
•-KTx-24.1  VAKCSTSECGHACQQAGCRNSGCRYGSCICVGC 715 
•-KTx-25.1  Empty 716 
•-KTx-26.1  NFKVEGACSKPCRKYCIDKGARNGKCINGRCHCYY 717 
•-KTx-27.1  QIDINVSCRYGSDCAEPCKRLKCLLPSKCINGKCTCYPSIKIKNCKVQTY 718 
•-KTx-28.1  ACVTHEDCTLLCYDTIGTCVDGKCKCM 719 
•-KTx-29.1  EGDCPISEAIKCVEKCKEKVEVCEPGVCKCSG 720 
•-KTx-30.1  EDKLKCTKTDDCAKYCSQFTDVHPACLGGYCECLRWEGGISS 721 
•-KTx-31.1  AGSMDSCSETGVCMKACSERIRQVENDNKCPAGECICTT 722 
 723 
 724 
Only the first the number 1 toxin of each subfamily was selected. The number α-KTx 25 is empty 725 
 726 
 727 
 728 
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Highligths 
1. Two short length peptides: Pi5 and Pi6 were purified and characterized from 
Pandinus imperator scorpion venom. 
2. Pi5 has 33 amino acids and constitutes a new subfamily of α-KTx, (systematic 
number α-KTx 24.1). 
3. Pi6 contains 28 amino acids, two disulfide bonds, and is a new member of the κ-
KTx (systematic number κ-KTx2.9). 
4. Pi5 inhibited Shaker B, hKv1, Kv1.2 and hKv1.3 channels at nanomolar 
concentrations. 
5. Pi6 is a non-selective blocker of hKv1.2 and hKv1.3 channels. 
 
